MedTrace Logo

Hybrid Operation in Thoracic Aortic Dissection

NCT01500395 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-01-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the short to mid term efficacy and safety of different hybrid operations who had complex aortic lesions, such as ascending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type A dissection, retrograde Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Conditions

  • Aorta Dissection
  • Aorta Aneurysm

Interventions

PROCEDURE

Hybrid operation

Hybrid Operations including debranching technique+Thoracic Endovascular Aortic Repair (TEVAR), Frozen elephant trunk technique, aortic arch replacement with concommitant TEVAR, et al. Devices include Medtronic Stent Graft（Medtronic Medtronic, Inc., US） Microport Stent Graft（Microport Co.,LTD.，Shanghai, China） Ankura Stent Graft（Lifetech Scientific Co.,LTD.，Shenzhen, China）.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Changhai Hospital

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Dinghua Yi, M.D., Ph.D · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Jian Yang, M.D., Ph.D. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Weixun Duan, M.D., Ph.D. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Shiqiang Yu, M.D. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Jincheng Liu, M.D. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

  • Wensheng Chen, M.D. · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500395 on ClinicalTrials.gov